TELA Bio, Inc. (TELA) Operating cash flow 2017–2025
TELA Bio, Inc. (TELA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.2MFY2025 · since FY2017: -$16.4M → -$28.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.2M | +32.2% |
| FY2024 | -$41.6M | -1.8% |
| FY2023 | -$40.9M | -0.3% |
| FY2022 | -$40.7M | -33.9% |
| FY2021 | -$30.4M | -24.4% |
| FY2020 | -$24.5M | +4.2% |
| FY2019 | -$25.5M | -28.1% |
| FY2018 | -$19.9M | -21.7% |
| FY2017 | -$16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating marginTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →